BRIEF-Abivax announces ABX203 was granted Cuban marketing authorization

martes 8 de diciembre de 2015 13:12 GYT
 

Dec 8 (Reuters) - Abivax SA :

* ABX203 granted Cuban marketing authorization to treat chronic Hepatitis B under the trade name HeberNasvac Source text for Eikon: Further company coverage: (Gdynia Newsroom)